Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies and methods of using same for treating ErbB/ErbB ligands associated diseases

Antibodies and methods of using same for treating ErbB/ErbB ligands associated diseases

US Patent 9518988 · Granted Dec 13, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti amphiregulin antibodies, compositions comprising same and uses thereof2020
Anti amphiregulin antibodies, compositions comprising same and uses thereof2020
Anti-HER3 antibodies and uses of same2020
Anti-HER3 antibodies and uses of same2020
Compositions and methods for treating cancer resistant to a tyrosine kinase inhi2018
Aptamers, multimeric aptamers and uses thereof2018
Combination therapy to prevent DCIS formation and progression to breast cancer2016
Antibody combinations and use of same for treating cancer2016
Combinations of anti ErbB antibodies for the treatment of cancer2015
Antibody combinations and use of same for treating cancer2014
Growth factor which acts through ErbB-4 RTK2011
Anti-EGFR antibodies with an improved anti-tumor activity and compositions and a2011